cystic fibrosis Flashcards

1
Q

ethnicity and CF

A

more common in European descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is CF?

A
  • autosomal recessive genetic disorder
  • mutation in a single gene on the long arm of chr 7
  • most common mutation is the delta F508 (deletion, pehenylalanine at position 508)
  • high salt concs in sweat (‘sweat test’)
  • thick and sticky mucous becayse of lack of water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CFTR (mutation)

A

cyctic fibrosis transmembrane conductance regulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

diagnosis of CF

A
  1. newborn screening with ‘heel prick’ test - measure immunoreactive trypsinogen levels in blood
  2. genetic mutation analysis
  3. sweat test - measures the conc of chloride excreted in sweat (inc in CF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

problems CF causes in the body

A
  • excessive salt loss in sweat
  • OP
  • growth retardation
  • respiratory failure
  • GI disorders
  • infertility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pulmonary effects of CF

A
  • impaired mucociliary clearance
  • airways clogged with thick sticky mucous
  • impairs clearance of microorganisms
  • early colonisation of lungs with Staphylococci or H influenzae
  • infections cause large inflam response
  • act of neutrophils
  • acc of debris from bacteria and neutrophils difficult to clear
  • proteases of neutrophils damage airways
  • cycle of infection & inflamm continues, lung fxn compromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

airway infections

A
  • close monitoring of secretions (cough, swab, sputum culture)
  • reg mon of lung fxn with spirometry, O2 sats
  • without ABX can deteriorate quickly, fatal respiratory failire
  • Tx threshold diff to no CF person
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

staphylococcus aureus

A
  • usually initial infecting pathogen
  • continuous prophylaxis as child
  • minor exacerbations - oral flucloxacillin
  • severe exacerbation - IV flucloxacillin or vancomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MRSA

A
  • pt/family swabbed
  • if in nasal - Tx with Mupirocin
  • MRSA causing Sx - fusicid acid + rifampicin/trimethoprim, oral linezolid
  • severe/acute exac - IV teicoplanin/vancomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

haemophilus influenzae Tx

A
  • oral amoxicillin
    (if sensitive and no recent Hx of s/ aureus)
  • severe infections - chloramphenicol, cefuroxine (cephalosporin, tendonitis, seizure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pseudomonas aeruginosa

A
  • recurrent infections eventually lead to chronic colonisation
  • chronic colonisation causes rapid decline in lung fxn
  • pts have a 2-3 fold inc risk of death over 8yr period
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

exacerbations of P. aeruginosa

A
  • treat early infections aggressively (attempt eradication)
  • eradication regimens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

eradication regimens for P aeruginosa

A
  1. 6 weeks ciprofloxacin and 3-6mth colistin
  2. 3 mths ciprofloxacin and colistin
  3. inhaled tobramycin (intol to ciprofloxacin and colitin or early regrowth of P aeruginosa or other Tx failed)

severe exacerbation, broad spec agets:
1. IV Tazocin
2. IV aminoglycosides (comb synergistic effect with beta latams)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

caution with IV aminoglycosides (gentamycin, tobramycin)

A

nephrotoxicity

ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

nebulised antibiotics

A
  • solution of drug into a fine spray
  • inhaled, delivering the ABX deep into the lungs
  • P. aeruginosa, reduce rate of lung deterioration and the number of IV courses needed
  • colistin and tobramycin have been used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

disadvantages of nebulised colistin and tobramycin

A

expensive

17
Q

doxycycline - counselling

A
  • sensitivity to sunlgiht
  • swallow whole, remain standing
18
Q

ciprofloxacin - counselling points

A
  • interacts with milk, antacids, Fe, Zn
  • risk of tendon rupture
  • may induce convulsions (caution in epilepsy)
19
Q

nebulised ABX - counselling points

A
  • bronchospasm - prevent by taking with bronchodilator (salbutamol)
  • 1st dose in hospital (measure lung fxn before and after)
  • may need filter to prevent fumes in room
20
Q

usual combination of ABX for CF infection

A

aminoglycoside + beta-lactam

21
Q

When are macrolides used?

A

LT in pts with declining lung function, declining clinical status and chronic colonisation

22
Q

eg of macrolide

A

azithromycin 250-500mg x3 WEEKLY

23
Q

3 mucoactive agents

A
  1. rhDNase
  2. hypertonic saline (HS)
  3. mannitol dry powder for inhalation (Bronchitol 40mg)
24
Q

rhDNase

A

rhDNase (dornase alpha, recombinant human deoxyribonuclease)
- CF sputum contains DNA derived from neutrophils
- aerolised rhDNase is an enzyme that cleaves DNA
- dec sputum viscosity and aid expectoration

25
Q

hypertonic saline (HS)

A

ST:
- induce sputum in pts where upper airway cultures are -ve
- adjunct to physio

LT:
- mucoactive agent
- adjunct to physio

26
Q

mannitol dry powder for inhalation (Bronchitol 40mg)

A
  • mannitol = sugar alcohol
  • inc hydration, aids clearance
  • 400mg BD
27
Q

aim for O2 sats

A

> 93%

28
Q

NIV - non-invasive ventilation

A
  • O2 therapy
  • useful for airway clearance with physio techniques
  • used LT, can improve gas exchange during sleep in mod/severe disease
29
Q

vaccines in CF

A
  • regular vaccines as per childhood
    immunisation schedule
  • annual flu vaccination strongly recommended (pt & family)
  • pneumococcal vaccination not required but offered if families prefer (not normally a problematic organism)
30
Q

physiotherapy

A
  • important for CF management
  • physical exercise
  • CV fitness = improved survival
  • airway clearance techniques
  • monitor MSK problems (posture, bone health)
31
Q

lung transplantation

A
  • option for end stage CF
  • criteria: limited life expectanct (<2yrs) & severely impaired QoL
  • 9yr survival post transplant
32
Q

pancreatic insufficiency

A
  • 95% of CF pts
  • need pancreatic enzyme replacement and fat sol vitamins (A, D, E, K)
  • more enzymes needed with fatty meal OR stools loose/frequent/oily/plale
  • Creon 10,000 caps in childern/adults
33
Q

CFRD - CF related diabetes

A
  • most common co-morbidity in CF
  • usually in adolecance/early adulthood
  • destruction of insulin producint islet cells
  • delayed and inufficient insulin secretion
  • reduced insulin sensitivity
  • Tx = insulin
  • microvasculat complications develop
34
Q

liver disease

A
  • genetic cholangiopathy
  • CFTR - expressed in liver, regulates fluid/electrolyte content of bile
  • dec fxn results in biliary cirrhosis
  • complications = portal hypertension, oesophageal varised, hepatic failure
35
Q

bone health

A
  • bone disease, low BMD
  • delayed puberty
  • steroid therapy
  • CF related diabetes
  • dec physical activity
  • Ca & Vit D deficiency
  • Vit K deficiency
  • poor nutritional status
  • chronic inflammaiton
36
Q

fertility

A
  • CBAVD - congenital absence of the vas deferens
  • most male CF pts will be infertile (not all(
  • normal fertility in females
  • interactions with COC (rifampicin)
37
Q

nutrition

A
  • improved nutritonal status = better outcomes & survival
  • poor body weight and height related to mottality
  • daily energy requirements 100-150% of average for age
  • high energy meals and snacks to achieve energy requirements and maintain weight
38
Q

new therapies in CF

A
  • Lumacaftor-ivacaftor (Orkambi) combination tablet
  • lumacoftor = CFTR corrector, improves cellular processing
  • ivacaftor = CFTR potentiator, inc probability the channel is open
  • only if homozygous for F508del mutation
39
Q

triple combination new therapy for CF

A

elexacaftor + tezacaftor + ivacaftor2